Related Experiment Videos
Lichen sclerosus
P D Yesudian1, H Sugunendran, C M Bates
1Department of Dermatology, Countess of Chester Hospital, Liverpool Road, Chester CH2 1UL, UK. Paul.Yesudian@coch.nhs.uk
International Journal of STD & AIDS
|July 12, 2005
Summary
Lichen sclerosus (LS) is a chronic inflammatory skin condition affecting all ages. Potent topical corticosteroids are the primary treatment for this relapsing disorder, which requires long-term monitoring.
Area of Science:
- Dermatology
- Genitourinary Medicine
Background:
- Lichen sclerosus (LS) is a chronic inflammatory disorder affecting skin and mucosa.
- It impacts both sexes and all age groups, with uncertain etiology involving genetic, infectious, and autoimmune factors.
Purpose of the Study:
- To provide a comprehensive overview of lichen sclerosus, including its presentation, diagnosis, and management.
- To highlight the importance of a multidisciplinary approach and long-term monitoring for patients with LS.
Main Methods:
- Review of clinical presentation, characteristic histopathology, and common symptoms like pruritus and soreness.
- Discussion of treatment modalities, primarily potent topical corticosteroids.
- Consideration of potential complications such as scarring and squamous cell carcinoma.
Main Results:
- LS presents with atrophic white plaques, particularly in the anogenital region.
- Histopathology shows specific changes including basal cell degeneration and dermal edema.
- The condition is typically remitting and relapsing, necessitating ongoing management.
Conclusions:
- Topical corticosteroids are the mainstay treatment for lichen sclerosus.
- Long-term monitoring and a multidisciplinary approach are crucial for managing this chronic condition.
- Awareness of potential complications like squamous cell carcinoma is essential.